Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience

Figure 3

Progressively decreasing number of patients with multiple MRONJ lesions from 2003 to 2015.